The drop in coverage for routine vaccinations against diseases like measles, mumps and rubella (MMR) increase the chances of an outbreak and underscore the continued fallout from barriers to vaccination during the COVID-19 pandemic.
New data from the Centers for Disease Control and Prevention (CDC) show cases are at the highest level in at least 30 years. There were more than 3,700 infants born with syphilis in 2022, a tenfold increase over the past 10 years.
...Previous studies have revealed disparities in COVID-19-related deaths among population demographics, including age, race and pre-existing medical conditions, but a new study by the University of Minnesota School of Public Health (SPH) has determined another factor – a person’s profession.
A study based on 211 pregnant women given the antiviral drug nirmatrelvir and ritonavir (Paxlovid) during pregnancy for acute COVID-19 infections shows no increased risk of adverse events in the women or their babies and a reduced risk of complications called the maternal morbidity and mortality index (MMMI).
The findings, published today in Nature Medicine, suggest the drug is safe to use in pregnancy and is effective in reducing MMMI risk but not COVID-related hospitalizations.
“Widespread access [to the new antibody drug] will take time across many sectors of the pediatric population and won’t have as great an impact on volumes this immediate respiratory season,” the Children’s Hospital Association said in a statement.
Why do some people have a more severe course of COVID-19 disease than others? A genome sequence database created by an international collaboration of researchers, including many from the University of Toronto and partner hospitals, may hold the answers to this question—and many more.
People with severe mental illness (SMI) are at a 50% increased risk of death from all causes following COVID-19 infections, according to a study yesterday in TheBritish Journal of Psychiatry.
